CYCLOPHOSPHAMIDE
- Product NDC
- 54879-022
- 11-digit product format
- 548790022
- Labeler code
- 54879
- Product ID
- 54879-022_ee2521c8-3bcc-1b0e-e053-2995a90a5578
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CYCLOPHOSPHAMIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- STI Pharma LLC
- Application
- ANDA209872
- Marketing category
- ANDA
- Marketing start
- 2018-05-08
- Marketing end
- 0000-00-00
- Substance
- CYCLOPHOSPHAMIDE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Alkylating Activity [MoA], Alkylating Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 54879-022 | CYCLOPHOSPHAMIDE CAPSULE [STI PHARMA LLC] | 6 | Legacy NDC | 20240113_4ebe66e7-5e0d-41ff-8ef9-e4c30a65f213.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 54879-022-01 | 54879002201 | 100 CAPSULE in 1 BOTTLE (54879-022-01) | 100 capsule | 2018-05-08 | 0000-00-00 | No | No | Current |